Characterization of hepatitis virus B isolated from a multi-drug refractory patient (Q45372133)

13 December 2017

title

Characterization of hepatitis virus B isolated from a multi-drug refractory patient (English)

1 reference

13 December 2017

main subject

viral drug resistance

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20970466

8 August 2024

viral genome

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20970466

8 August 2024

Chen Wei

1 reference

13 December 2017

Yu-Tian Chong

1 reference

13 December 2017

Ji-Zhi Wen

1 reference

13 December 2017

Yong-Wei Li

1 reference

13 December 2017

Gang Li

1 reference

13 December 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20970466

8 August 2024

publication date

21 October 2010

1 reference

full work available at URL

13 December 2017

https://api.elsevier.com/content/article/PII:S0168170210003771?httpAccept=text/xml

1 reference

10.1016/J.VIRUSRES.2010.10.018

DOI

https://api.crossref.org/works/10.1016/J.VIRUSRES.2010.10.018

https://api.elsevier.com/content/article/PII:S0168170210003771?httpAccept=text/plain

8 August 2024

1 reference

10.1016/J.VIRUSRES.2010.10.018

DOI

https://api.crossref.org/works/10.1016/J.VIRUSRES.2010.10.018

8 August 2024

1 reference

13 December 2017

volume

155

1 reference

13 December 2017

1 reference

13 December 2017

page(s)

254-258

1 reference

Lamivudine and Famciclovir resistant hepatitis B virus associated with fatal hepatic failure

13 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.10.018

Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.10.018

Long-term incidence of hepatitis B virus resistance to lamivudine in human immunodeficiency virus-infected patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.10.018

Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.10.018

Hepatitis B virus: significance of naturally occurring mutants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.10.018

Selection of hepatitis B virus polymerase mutants with enhanced replication by lamivudine treatment after liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.10.018

Susceptibility to antivirals of a human HBV strain with mutations conferring resistance to both lamivudine and adefovir.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.10.018

Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.10.018

Emergence and takeover of YMDD motif mutant hepatitis B virus during long-term lamivudine therapy and re-takeover by wild type after cessation of therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.10.018

Entecavir resistance is rare in nucleoside naïve patients with hepatitis B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.10.018

The hepatitis B virus polymerase mutation rtV173L is selected during lamivudine therapy and enhances viral replication in vitro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.10.018

Quasispecies and its impact on viral hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.10.018

Resistance of human hepatitis B virus to reverse transcriptase inhibitors: from genotypic to phenotypic testing.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.10.018

Adefovir-resistant hepatitis B can be associated with viral rebound and hepatic decompensation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.10.018

Dynamics of hepatitis B virus resistance to entecavir in a nucleoside/nucleotide-naïve patient

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.10.018

Treatment paradigms on hepatitis B e antigen-negative chronic hepatitis B patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.10.018

Hepatitis B genotypes and the response to interferon therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.10.018

Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.10.018

Hepatitis B virus variants in patients receiving lamivudine treatment with breakthrough hepatitis evaluated by serial viral loads and full-length viral sequences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.10.018

Hepatitis B viral resistance: mechanisms and diagnosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.10.018

T cell receptor usage of virus-specific CD8 cells and recognition of viral mutations during acute and persistent hepatitis B virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.10.018

Identification of a new variant in the YMDD motif of the hepatitis B virus polymerase gene selected during lamivudine therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.10.018

Mutations in the precore region of hepatitis B virus DNA in patients with fulminant and severe hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.10.018

HBV drug resistance: mechanisms, detection and interpretation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.10.018

Hepatitis B virus escape mutants induced by antiviral therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.10.018

Hepatitis B virus infection: epidemiology and vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.10.018

Clinical emergence of entecavir-resistant hepatitis B virus requires additional substitutions in virus already resistant to Lamivudine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.10.018

Restoration of replication phenotype of lamivudine-resistant hepatitis B virus mutants by compensatory changes in the "fingers" subdomain of the viral polymerase selected as a consequence of mutations in the overlapping S gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.10.018

Selection of a hepatitis B virus strain resistant to adefovir in a liver transplantation patient.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.10.018

Fatal hepatic failure after emergence of the hepatitis B virus mutant during lamivudine therapy in a patient with liver cirrhosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.10.018

Universal primers for HBV genome DNA amplification across subtypes: a case study for designing more effective viral primers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.10.018

Antigenic determinants and functional domains in core antigen and e antigen from hepatitis B virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.10.018

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VIRUSRES.2010.10.018

1 reference

13 December 2017

1 reference